Insider trades
Adam S. Grossman, CEO of Adma Biologics ADMA, has filed 0 purchases and 31 sales on the open market. Over the past 12 months that comes to a net sale of $1.7M. The latest trade was on 03/16.
Adam S. Grossman
President and CEO
- Company
- Adma Biologics ADMA
- First filing
- 23/01/06
- Trades
- 117 trades
- Buys / sales
- 0 / 31
- 12-month net buying
- −$1.7M
- Last trade
- 03/16
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ADMA | Open-market sale10b5-1 plan | 03/16 | 03/17 | 21,000 sh2 trades | $15.16avg. | $318,360 | −1.0% |
ADMA | Open-market sale10b5-1 plan | 02/17 | 02/17 | 21,000 sh2 trades | $16.08avg. | $337,680 | −0.9% |
ADMA | Open-market sale10b5-1 plan | 25/12/15 | 25/12/16 | 21,000 sh2 trades | $19.79avg. | $415,590 | −1.0% |
ADMA | Open-market sale10b5-1 plan | 25/11/19 | 25/11/21 | 21,000 sh2 trades | $16.00avg. | $336,000 | −1.0% |
ADMA | Open-market sale10b5-1 plan | 25/10/24 | 25/10/24 | 21,000 sh2 trades | $16.00avg. | $336,000 | −1.0% |
ADMA | Open-market sale10b5-1 plan | 25/09/15 | 25/09/16 | 21,000 sh2 trades | $16.13avg. | $338,730 | −1.0% |
ADMA | Open-market sale10b5-1 plan | 25/08/15 | 25/08/15 | 21,000 sh2 trades | $16.88avg. | $354,480 | −1.0% |
ADMA | Open-market sale10b5-1 plan | 25/07/15 | 25/07/16 | 21,000 sh2 trades | $18.66avg. | $391,860 | −1.0% |
ADMA | Open-market sale10b5-1 plan | 25/06/16 | 25/06/18 | 21,000 sh2 trades | $20.81avg. | $437,010 | −1.0% |
ADMA | Open-market sale10b5-1 plan | 25/05/15 | 25/05/16 | 21,000 sh2 trades | $19.45avg. | $408,450 | −1.0% |
ADMA | Open-market sale10b5-1 plan | 25/04/15 | 25/04/16 | 21,000 sh2 trades | $21.46avg. | $450,660 | −1.0% |
ADMA | Open-market sale10b5-1 plan | 25/03/19 | 25/03/21 | 21,000 sh2 trades | $18.92avg. | $397,320 | −1.0% |
Adma BiologicsADMA | Open-market sale | 24/11/22 | 24/11/22 | 48,967 sh | $21.10 | $1,033,203.7 | −2.4% |
ADMA | Open-market sale | 24/08/26–24/08/27 | 24/08/27 | 626,245 sh2 trades | $17.44avg. | $10,922,531.65 | −23.3% |
Adma BiologicsADMA | Open-market sale | 24/06/14 | 24/06/14 | 100,000 sh | $10.72 | $1,072,000 | −4.6% |
Adma BiologicsADMA | Open-market sale | 23/08/18 | 23/08/18 | 250,000 sh | $4.15 | $1,037,500 | −9.9% |
ADMA | Open-market sale | 23/08/15–23/08/16 | 23/08/17 | 510,472 sh2 trades | $4.54avg. | $2,317,542.43 | −16.8% |